Large Language Models and the Future of Peer-Reviewed Medical Publishing: Challenges, Editorial Responses, and a Framework for Responsible Integration.

IF 3.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Hyejin Joo, Munkhzul Radnaabaatar, Jaehun Jung
{"title":"Large Language Models and the Future of Peer-Reviewed Medical Publishing: Challenges, Editorial Responses, and a Framework for Responsible Integration.","authors":"Hyejin Joo, Munkhzul Radnaabaatar, Jaehun Jung","doi":"10.3346/jkms.2026.41.e306","DOIUrl":null,"url":null,"abstract":"<p><p>The public release of large language models (LLMs) in late 2022 has fundamentally altered the landscape of scholarly medical publishing. LLMs now permeate every stage of the academic publishing pipeline, from manuscript drafting and peer review to editorial decision-making, with evidence suggesting that at least 13.5% of biomedical abstracts published in 2024 showed detectable LLM involvement. This rapid adoption has intersected with pre-existing structural vulnerabilities, including escalating article processing charges, publish-or-perish incentives, a chronic peer reviewer shortage, and inadequate editorial resources, creating interconnected challenges that affect all stakeholders. The response from the scholarly publishing community has been substantial but fragmented. International standards bodies, such as the International Committee of Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), World Association of Medical Editors (WAME), have established consensus principles prohibiting AI authorship and requiring disclosure, yet individual journals range from restrictive to actively encouraging in their AI policies, and detection-based enforcement approaches have proven fundamentally unreliable, with documented biases against non-native English speakers. This narrative review characterizes the structural challenges of LLM adoption in medical publishing, provides a systematic comparison of editorial policies across major medical journals and publishers, and examines the limitations of current detection and enforcement mechanisms. Rather than focusing on prohibition and policing, the review proposes a forward-looking framework centered on three concrete proposals: 1) a three-tiered disclosure system (assistive, augmentative, substantive) integrated with the CRediT taxonomy; 2) a four-stage artificial intelligence co-editor model for deploying LLM-based tools within editorial workflows under transparent governance principles; and 3) equity-conscious policy design with international coordination through a proposed global editorial summit. The framework aims to shift the editorial paradigm from reactive enforcement to proactive governance, addressing the operational reality that editors are overburdened and underresourced for the expanding expectations placed upon them.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"41 29","pages":"e306"},"PeriodicalIF":3.2000,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13406950/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3346/jkms.2026.41.e306","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

The public release of large language models (LLMs) in late 2022 has fundamentally altered the landscape of scholarly medical publishing. LLMs now permeate every stage of the academic publishing pipeline, from manuscript drafting and peer review to editorial decision-making, with evidence suggesting that at least 13.5% of biomedical abstracts published in 2024 showed detectable LLM involvement. This rapid adoption has intersected with pre-existing structural vulnerabilities, including escalating article processing charges, publish-or-perish incentives, a chronic peer reviewer shortage, and inadequate editorial resources, creating interconnected challenges that affect all stakeholders. The response from the scholarly publishing community has been substantial but fragmented. International standards bodies, such as the International Committee of Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), World Association of Medical Editors (WAME), have established consensus principles prohibiting AI authorship and requiring disclosure, yet individual journals range from restrictive to actively encouraging in their AI policies, and detection-based enforcement approaches have proven fundamentally unreliable, with documented biases against non-native English speakers. This narrative review characterizes the structural challenges of LLM adoption in medical publishing, provides a systematic comparison of editorial policies across major medical journals and publishers, and examines the limitations of current detection and enforcement mechanisms. Rather than focusing on prohibition and policing, the review proposes a forward-looking framework centered on three concrete proposals: 1) a three-tiered disclosure system (assistive, augmentative, substantive) integrated with the CRediT taxonomy; 2) a four-stage artificial intelligence co-editor model for deploying LLM-based tools within editorial workflows under transparent governance principles; and 3) equity-conscious policy design with international coordination through a proposed global editorial summit. The framework aims to shift the editorial paradigm from reactive enforcement to proactive governance, addressing the operational reality that editors are overburdened and underresourced for the expanding expectations placed upon them.

大型语言模型和同行评议医学出版的未来:挑战、编辑回应和负责任整合的框架。
2022年末公开发布的大型语言模型(llm)从根本上改变了学术医学出版的格局。法学硕士现在渗透到学术出版渠道的每一个阶段,从手稿起草、同行评审到编辑决策,有证据表明,2024年发表的生物医学摘要中至少有13.5%显示出法学硕士的参与。这种快速采用与先前存在的结构性漏洞交织在一起,包括不断上涨的文章处理费用、“要么发表,要么消亡”的激励机制、长期的同行审稿人短缺和编辑资源不足,这些都产生了影响所有利益相关者的相互关联的挑战。学术出版界对此的反应是实质性的,但却是零散的。国际标准机构,如国际医学期刊编辑委员会(ICMJE)、出版伦理委员会(COPE)、世界医学编辑协会(WAME),已经建立了禁止人工智能作者身份并要求披露的共识原则,但个别期刊在其人工智能政策方面从限制到积极鼓励不等,基于检测的执法方法已被证明从根本上不可靠。对非英语母语者有偏见。这篇叙述性综述描述了医学出版采用法学硕士的结构性挑战,对主要医学期刊和出版商的编辑政策进行了系统比较,并检查了当前检测和执行机制的局限性。与侧重于禁止和监管不同,该报告提出了一个前瞻性框架,其核心是三项具体建议:1)与信用分类相结合的三层披露制度(辅助、补充、实质性);2)一个四阶段人工智能联合编辑模型,用于在透明治理原则下在编辑工作流程中部署基于法学硕士的工具;3)通过提议的全球编辑峰会进行具有公平意识的政策设计和国际协调。该框架旨在将编辑模式从被动执行转变为主动治理,解决编辑负担过重和资源不足的操作现实,以满足对他们不断扩大的期望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Korean Medical Science
Journal of Korean Medical Science 医学-医学:内科
CiteScore
7.80
自引率
8.90%
发文量
320
审稿时长
3-6 weeks
期刊介绍: The Journal of Korean Medical Science (JKMS) is an international, peer-reviewed Open Access journal of medicine published weekly in English. The Journal’s publisher is the Korean Academy of Medical Sciences (KAMS), Korean Medical Association (KMA). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书